Trial Profile
Rabeprazole Prevents Gastric Mucosal Injury Induced By Low-Dose Aspirin and Clopidogrel
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 May 2012
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Rabeprazole (Primary) ; Aspirin
- Indications Acute coronary syndromes; Gastric damage; Gastrointestinal disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacogenomic
- 22 May 2012 Results presented at the Digestive Disease Week 2012.
- 08 Jun 2011 New trial record
- 10 May 2011 Results presented at the Digestive Disease Week 2011.